BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of xenobiotics
,
Allergy to pollen
,
Hippocampus
,
Pharmacogenetics
,
PDX1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
factor IX
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
OMIM - Hereditary disorder by system
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Human coagulation factor IX: a systematic review of its characteristics.
Recombinant factor IX Fc for the treatment of hemophilia B.
Complete F9 Gene Deletion, Duplication, and Triplication Rearrangements: Implications for Factor IX …
Current factor IX replacement options for hemophilia B and the challenges ahead.
Plasma levels of coagulation factors VIII and IX and risk of venous thromboembolism: Systematic revi…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency
Factor IX as Adjunctive Therapy to Emicizumab (EMIX)
Natural History Study of Factor IX Treatment and Complications
A Study to Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX i…
Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ